Literature DB >> 6937465

Purification and properties of a 3 beta-hydroxy-delta 5-C27-steroid oxidoreductase from rabbit liver microsomes.

K Wikvall.   

Abstract

The enzyme converting 5-cholestene-3 beta, 7 alpha-diol to 7 alpha-hydroxy-4-cholesten-3-one has been solubilized from rabbit liver microsomes by treatment with a mixture of sodium cholate and the nonionic detergent Renex 690. The enzyme was purified about 200-fold, with a recovery of more than 50%, by chromatography on DEAE-cellulose, hydroxylapetite, 2',5',ADP-Sepharose 4B and 5'-AMP-Sepharose 4B. The purified enzyme showed only one protein band, with an apparent molecular weight of 46,000, on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The enzyme was eluted as a single peak on gel filtration on Ultrogel AcA 34. The elution volume corresponded to that observed for globular proteins with molecular weights in the 45,000 to 50,000 region. The substrate specificity of the microsomal fraction and of the purified oxidoreductase in oxidation and reduction of various 3-oxygenated C19-, C21-, and C27-steroids was studied in the presence of NAD and NADH. Whereas the microsomal fraction had a broad substrate specificity, NAD-supported oxidation with the purified oxidoreductase only occurred with 5-cholestene-3 beta, 7 alpha-diol as substrate. NADP could not replace NAD in the reaction. NADH-supported reduction with the purified oxidoreductase only occurred with 7 alpha-hydroxy-5 alpha-cholestan-3-one as substrate. The results suggest that conversion of 5-cholestene-3 beta, 7 alpha-diol to 7 alpha-hydroxy-4-cholesten-3-one is catalyzed by a single enzyme specific for certain C27-steroids.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6937465

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis.

Authors:  K D Setchell; F J Suchy; M B Welsh; L Zimmer-Nechemias; J Heubi; W F Balistreri
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

2.  Treatment of chronic liver disease caused by 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency with chenodeoxycholic acid.

Authors:  H Ichimiya; H Nazer; T Gunasekaran; P Clayton; J Sjövall
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

Review 3.  Biosynthesis of bile acids in mammalian liver.

Authors:  S Kevresan; K Kuhajda; J Kandrac; J P Fawcett; M Mikov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jul-Sep       Impact factor: 2.441

4.  The bile acid synthetic gene 3beta-hydroxy-Delta(5)-C(27)-steroid oxidoreductase is mutated in progressive intrahepatic cholestasis.

Authors:  M Schwarz; A C Wright; D L Davis; H Nazer; I Björkhem; D W Russell
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 5.  Fifty years of advances in bile acid synthesis and metabolism.

Authors:  David W Russell
Journal:  J Lipid Res       Date:  2008-09-24       Impact factor: 5.922

6.  Familial giant cell hepatitis associated with synthesis of 3 beta, 7 alpha-dihydroxy-and 3 beta,7 alpha, 12 alpha-trihydroxy-5-cholenoic acids.

Authors:  P T Clayton; J V Leonard; A M Lawson; K D Setchell; S Andersson; B Egestad; J Sjövall
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

Review 7.  Mechanisms of disease: Inborn errors of bile acid synthesis.

Authors:  Shikha S Sundaram; Kevin E Bove; Mark A Lovell; Ronald J Sokol
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-06-24

8.  The role of sterol carrier protein2 and other hepatic lipid-binding proteins in bile-acid biosynthesis.

Authors:  B Lidström-Olsson; K Wikvall
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

9.  Lack of 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase/isomerase in fibroblasts from a child with urinary excretion of 3 beta-hydroxy-delta 5-bile acids. A new inborn error of metabolism.

Authors:  M S Buchmann; E A Kvittingen; H Nazer; T Gunasekaran; P T Clayton; J Sjövall; I Björkhem
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.